Skip to main content
×

GE.com has been updated to serve our three go-forward companies.

Please visit these standalone sites for more information

GE Aerospace | GE Vernova | GE HealthCare 

Employees

Close to Home: How One Engineer Dedicates His Life to Bringing Better Imaging Technology to Colombia

Margaret Steinhafel
December 06, 2022
header-image

In western Colombia — surrounded by towering mountains, an active volcano, and lush green coffee plants — lies the picturesque city of Manizales. In addition to being the heart of Colombian coffee production, the small community is also the hometown of Jorge Uribe and his father, mother, brother, and two sisters.

Press Release

GE Healthcare and Theragnostics announce global commercial partnership for late stage PSMA diagnostic for prostate cancer

October 09, 2019
  • Theragnostics’ novel PET tracer, GalliProst, will help visualize prostate cancer to enable personalized treatment.
  • The two companies will leverage their combined scientific, commercial and market access expertise to work towards a commercial launch.

Chalfont St Giles, UK – October 9th 2019 GE Healthcare and Theragnostics have entered into a global commercial partnership for a new Prostate-Specific Membrane Antigen (PSMA) PET/CT imaging agent.

For media inquiries, please contact:

David Morris
Communications Director, Pharmaceutical Diagnostics
GE Healthcare
+44 7920591370
[email protected]
Europe/London

business unit
tags
Press Release

Personalized Care from Disease Detection through Treatment Assessment: GE Healthcare Announces FDA Clearance of Discovery IQ

September 22, 2014

WAUKESHA, Wis. -- September 22, 2014 -- GE Healthcare today announced U.S. FDA 510(k) clearance of its Discovery* IQ PET/CT system, enabling both outstanding image quality and intelligent quantitation to help physicians deliver the best possible patient outcomes.


business unit
tags
Press Release

Smart. Simple. Complete. GE Healthcare's Latest Innovations in Cancer Care on Display at ASTRO 2014

September 15, 2014

Multidisciplinary solutions to help integrate planning and improve quantitation and efficiency in radiation oncology


business unit
tags
Press Release

Personalized Care from Disease Detection through Treatment Assessment Enabled with GE Healthcare's Discovery IQ

June 09, 2014

ST. LOUIS -- Today at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE Healthcare introduced its Discovery* IQ^ PET/CT system, enabling both outstanding image quality and intelligent quantitation, helping physicians deliver the best possible patient outcomes.


business unit
tags
Press Release

GE Healthcare Receives FDA Clearance for Q.Clear Technology

April 08, 2014

Technology can enable clinicians to assess patient's response to treatment accurately

WAUKESHA, Wisc. -- April 8, 2014 -- GE Healthcare, a unit of General Electric Company (NYSE: GE), today announced that it received U.S. FDA 510(k) clearance of its Q.Clear^ technology -- technology that can provide up to two times improvement in both quantitative accuracy and image quality in PET/CT imaging. This is an innovative new tool for clinicians across the entire care continuum including diagnosis, staging, treatment planning, and treatment assessment.


business unit
tags
Press Release

The Breast Care Continuum, The Full Spectrum of Breast Care from Screening and Diagnosis through Monitoring

March 26, 2014
Press Release

GE Healthcare Delivers Innovative Technology to Advance Cancer Care

December 04, 2013

CHICAGO -- December 4, 2013 -- As part of its ongoing commitment to accelerating cancer innovation and assembling tools to fight the disease, GE Healthcare, a unit of General Electric Company (NYSE: GE), will highlight the benefits of the company's broad portfolio of advanced cancer treatment solutions at the 2013 Radiological Society of North America (#RSNA13) annual meeting.


business unit
tags
Press Release

GE Healthcare Showcases Latest Innovations in Cancer Care at ASTRO 2013

September 22, 2013

New solutions help integrate planning, improve visualization and enable improved clinical productivity for radiation oncology


business unit
tags
Press Release

SNMMI 2013 Image of the Year Captured on GE Healthcare PET/CT Technology

August 12, 2013

MILWAUKEE - GE Healthcare announced today that its Discovery* PET/CT 690 and PET VCAR 2.0 were used by Professor Patrick Flamen of the Institut Jules Bordet in Brussels in capturing the Society of Nuclear Medicine and Molecular Imaging 2013 "Image of the Year."

Professor Flamen's winning scan illustrated the effectiveness of radium-223 dichloride in treating bone metastases in breast cancer patients with bone-dominant disease. It was selected as the winning image from more than 2,000 studies.


business unit
tags
Subscribe to PET-CT